Soft Q1, FY27 target at risk; H2 recovery hoped, execution delays loom
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
FY27 revenue guidance (15%/₹6,500 Cr) formally maintained but increasingly unrealistic. ₹7,500 Cr milestone pushed to FY28. Execution track record shows delays (GMLR tree-cutting took 10 months; Vadhvan hampered by monsoon and land issues).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 revenue growth of 1.8% badly misses FY27 guidance of 15%, requiring 20%+ growth in remaining quarters. Margins compressed; PAT -5.8% YoY. Strong ₹22K Cr order book and disciplined margin culture are genuine, but major projects (GMLR, Vadhvan) are delayed, and execution risks are materializing. Management deferred ₹7,500 Cr target to FY28—a tacit acknowledgment that FY27 will underperform prior hopes.
₹1511.2 Cr
Revenue · +1.8% YoY₹97.4 Cr
Reported PAT · −5.8% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Q1 revenue growth of 2% YoY
METDelivered ₹1,511 Cr vs ₹1,484 Cr (1.8% actual)
EBITDA moderated 1% to ₹215 Cr
METDelivered ₹215 Cr; OPM 14.2% vs prior 14.6%
PAT moderated 6% to ₹97 Cr
METDelivered ₹97.4 Cr (6% decline matches)
15% FY27 revenue growth target (~₹6,500 Cr)
OVERSTATEDQ1 at only 1.8% growth; H2 must average ~20% to hit 15% FY
Strong order pipeline; ₹50,000-₹100,000 Cr upcoming
METQ1 inflows ₹5,500 Cr (announced); ₹1,500 Cr L1; pipeline real but timing uncertain
Earnings quality
What changed since the last call
Revenue growth target
MaintainedFY27 15% growth/₹6,500 Cr reaffirmed. But ₹7,500 Cr aspiration deferred from FY27 to FY28—implicit acknowledgment of lower FY27 outturn.
EBITDA margin guide
Maintained14-15% for FY27 (prior: 14-15% to 15-16% long-term). Q1 delivered 14.2%, slightly below. No formal cut.
Project timelines
DowngradeGMLR pushed Nov 2028 → June/Dec 2029 (2-year slip); Vadhvan ramp pushed to Q3 FY27 due to monsoon and land delays.
Order intake stance
Maintained₹8,000-₹10,000 Cr target held. Q1 ₹5,500 Cr (announced) + ₹1,500 Cr L1 = ₹7,000 Cr YTD; on track.
Capex guidance
Maintained₹150 Cr/year (incl. maintenance) for next 2 years. Major TBM/Chennai capex absorbed; no new large capex expected.
The Q&A
Analysts pressed hard on execution bottlenecks (Vedant Kabra) and the mismatch between strong order book and flat revenue (Kamal directly acknowledged land acquisition and approval delays slowed major projects). Management was candid but defensive—shifting blame to external factors (monsoon, BMC water ban) and emphasizing margin discipline over growth-at-all-costs. Tone was cautious, not evasive.
Project execution status — Vaibhav Shah, JM Financial
AnsweredChennai 20% done, target Dec 2028; Anand Nagar 15% done, Oct 28; GMLR TBM launching imminently, June/Dec 2029 completion.
Order inflow guidance — Vaibhav Shah, JM Financial
AnsweredTarget ₹8,000-₹10,000 Cr; currently ₹5,500 Cr (announced) + ₹1,500 Cr L1 (Delhi Metro) = ₹7,000 Cr.
Revenue growth sustainability — Vedant Kabra, AVN Capital
AnsweredLand acquisition and tree-cutting delays on major projects (GMLR, Chennai, VDCR) prevented ramp-up; now resolved, will accelerate H2 execution. Temporary bottleneck, not structural.
Depreciation and capex trajectory — Dhananjay, Centrum Broking
AnsweredQ4 had asset write-offs; Q1 normalized. Full-year ~₹60 Cr. Capex: ₹150 Cr/year (maintenance + project) for 2 years; major TBM/Chennai capex already done.
Working capital and debt trajectory — Shravan Shah, Dolat Capital
AnsweredWC improving, target 100-110 going forward. Gross debt ₹840 Cr due to TBM capex; will decline as term loan repaid. No further material debt expected.
Margin confidence — Shravan Shah, Dolat Capital
AnsweredYes, we aim to improve by 100 bps; don't work without margins. Even in low-growth FY26, maintained 14-15%.
Order book vs. revenue mismatch — Kamal Gupta, management
AnsweredProject approvals and land acquisition took 2 years for GMLR/Chennai/VDCR; all now in progress. New projects ramp from Q2-Q3.
FY27 revenue target feasibility — Shravan Shah, Dolat Capital
PartialH2 will be strong; Vadhvan, GMLR, new projects ramp Q3 onwards. Q2 also better than Q1, not flat.
Capex requirements for new orders — Thomas, Individual Investor
AnsweredMajor capex done. ₹150 Cr/year routine; unless major new equipment projects, no large capex planned.
Margin discipline philosophy — Dinesh Karwa, Kirti Creation
AnsweredWe prioritize margins over top-line growth. Won't take low-margin orders; better to stay at ₹6,500 Cr at healthy margins.
Guidance
FY27: 15% YoY growth, ~₹6,500 Cr
MediumPrior guidance reaffirmed. Q1 at 1.8% requires H2 ~20% growth to achieve. Feasibility contingent on new project ramps (Vadhvan Q3, others Q3-Q4).
EBITDA margin: 14-15% FY27; long-term 15-16%
HighDelivered 14.2% Q1; in range. Management reiterated discipline; no work without adequate margins.
PAT margin: ~7% (prior); delivered 6.4% Q1
MediumQ1 missed; management expects recovery H2 as new projects ramp and TBM capitalized (tax shelter).
₹150 Cr/year (total incl. maintenance) for FY27-28
HighQ1 capex ₹34 Cr; major TBM/Chennai capex already absorbed. Going forward, routine maintenance + opportunistic equipment only.
Risks the call surfaced
Project execution delays
HighGMLR 2-year delay; Vadhvan ramp pushed to Q3; Chennai only 20% complete. Large capex projects inherently risky; regulatory approvals slow.
Revenue growth shortfall vs. guidance
HighQ1 +1.8% YoY requires H2 ~20% growth to achieve 15% FY. New project ramps (Vadhvan, new orders) not yet proven; risk of sustained flat/low growth.
Margin pressure
MediumQ1 OPM 14.2% vs. prior 14.6%; PAT margin 6.4% vs. guidance ~7%. Project mix, cost inflation, or competitive bids could compress further.
Working capital and debt management
MediumGross debt ₹840 Cr (up from ₹580 Cr) due to TBM capex. WC days at 103; uptrend. If new projects front-load advances without cash collections, liquidity could tighten.
Order pipeline timing risk
Medium₹50,000-₹100,000 Cr pipeline (MSRDC, Uttan-Virar, MMRDA) exists but timing uncertain. Approvals and merging of routes can slip 3-6 months. Risk to ₹8,000-₹10,000 Cr FY27 target if awards defer to FY28.
Management
Score 6/10. Candid on project delays and margin trade-offs. Transparent about execution bottlenecks (land, approvals, monsoon). Defensive on FY27 growth target but forthright that ₹7,500 Cr milestone shifted to FY28. Mixed track record. FY26 guidance (15% growth) missed (flat revenue). Reasons credible (land/approvals) but not excuses. On margins, delivered within guidance. Current GMLR/Vadhvan delays are material but acknowledged and crash programs underway.
1 · Q2 FY27
DMRC L1 (₹1,500 Cr) expected to convert to order
2 · Q3 FY27
Vadhvan actual excavation begins; GMLR TBM drilling ramps
3 · Q3-Q4 FY27
New order inflows from MSRDC, Uttan-Virar, MMRDA projects
Management deferred ₹7,500 Cr target to FY28—a tacit acknowledgment that FY27 will underperform prior hopes.
Informational and educational content only. Not investment advice.